SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare
Cadila Healthcare
BSE: 532321|NSE: CADILAHC|ISIN: INE010B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 19, 11:34
1293.95
-2.8 (-0.22%)
VOLUME 697
LIVE
NSE
Sep 19, 11:34
1291.05
-6.1 (-0.47%)
VOLUME 10,294
News on Cadila Healthcare
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Stocks in news: Tata Motors, GTL Infra, ICICI, Cipla, SPML

8.22 am | 19 Sep 2014 |  Source: CNBC-TV18

Tata Motors | Tata Chemicals | Tata Steel | Tata Power | Tech Mahindra | Bosch | GTL Infrastructure | SBI | Axis Bank | ICICI Bank | Manappuram Financ...

Cadila Health up 3%, diabetic drug gets tentative USFDA nod

2.23 pm | 16 Sep 2014 |  Source: Moneycontrol.com

"Zydus Cadila has received tentative approval from the US Food and Drug Administration (US FDA) to market (anti-diabetic drug) Glipizide extended rele...

Zydus receives tentative approval for Glipizide ER tablets

12.13 pm | 16 Sep 2014 |  Source: Moneycontrol.com

Zydus Cadila has received tentative approval from USFDA to market Glipizide extended-release tablets in the strength of 2.5 mg, 5 mg and 10 mg. The dr...

Hope rally over: Why you should go back to 'boring sectors'

12.36 pm | 15 Sep 2014 |  Source: Moneycontrol.com

“The Street is building in a capex cycle of the likes in 2004 and 2008,” Elara says, adding, “while we do not dispute the recovery signals, we a...

Super Six stocks that should be on your radar today

8.45 am | 05 Sep 2014 |  Source: CNBC-TV18

Vishal Kshatriya, Edelweiss advises buying Cadila Healthcare for a target price of Rs 1,350 and Bata India for a target price of Rs 1,450....

Stocks in news: Maruti, JSPL, Wockhardt, Bharti, Cadila

8.22 am | 01 Sep 2014 |  Source: CNBC-TV18

ITC | DHFL | SKS Microfinance | Voltas | Maruti Suzuki | Tata Motors | Mahindra and Mahindra | TVS Motor | ONGC | JSPL | Hindalco Industries | Sesa St...

Zydus receives final approval for Telmisartan Tablets

12.43 pm | 30 Aug 2014 |  Source: Moneycontrol.com

Cadila Healthcare has informed regarding a Press Release dated August 29, 2014 titled ...

ITC replaces TCS as India's most admired company

8.30 am | 25 Aug 2014 |  Source: IBNLive.com

In the latest list for the year 2014, ITC is followed by engineering and infrastructure major Larsen and Toubro (L&T), another FMCG giant Hindustan Un...

Zydus Cadila gets USFDA nod for anti-viral drug Acyclovir

3.35 pm | 20 Aug 2014 |  Source: PTI

"Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets," the company said in a statement issued today....

Pharma stocks outperform equity benchmarks, rally 2-14%

3.26 pm | 20 Aug 2014 |  Source: Moneycontrol.com

Marksans Pharma surged 7 percent (up 200 percent year-to-date) while Orchid Chemicals gained 9 percent as it expects to increase capacity utilisation ...

Cadila Health at new high on USFDA nod for anti-viral drug

1.39 pm | 20 Aug 2014 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg....

Zydus receives final approval for Acyclovir Tablets

11.59 am | 20 Aug 2014 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Acyclovir Tablets in the strength of 400 mg and 800 mg. The drug falls under ant...

Prefer Ipca Lab, Tata Elexi, Mindtree: Dipan Mehta 

2.37 pm | 18 Aug 2014 |  Source: CNBC-TV18

Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Ipca Laboratories, Tata Elexi and Mindtree....

Focus on stocks, says Dipan Mehta; picks top 5 pharma bets 

11.45 am | 18 Aug 2014 |  Source: CNBC-TV18

Oil & gas stocks are benefiting from the lower burden of subsidy sharing and the pack may move higher on oil price correction, Dipan Mehta, member, BS...

Accumulate Cadila Healthcare; target of Rs 1220: KRChoksey

6.29 pm | 12 Aug 2014 |  Source: Moneycontrol.com

KRChoksey is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1220 in its July 31, 2014 research re...

Hold Cadila Healthcare; target of Rs 1300: Sharekhan

11.59 am | 05 Aug 2014 |  Source: Moneycontrol.com

Sharekhan has recommended a hold rating on Cadila Healthcare with a target price of Rs 1300 per share in its July 30, 2014 research report....

Buy Cadila Healthcare; target of Rs 1205: Motilal Oswal

6.05 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1205 in its July 30, 2014 research repor...

Accumulate Cadila Healthcare; tgt of Rs 1309: Dolat Capital

4.22 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Dolat Capital is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1309 in its July 30, 2014 researc...

Hold Cadila Healthcare; target of Rs 1059: ICICIdirect

1.44 pm | 01 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com has recommended hold rating on Cadila Healthcare with a target price of Rs 1059, in its research report dated July 31, 2014....

Dr Reddy's, Lupin, Glenmark top pharma bets: Nomura 

11.25 am | 31 Jul 2014 |  Source: CNBC-TV18

"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said....

1 2 3
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.